Snap-on Inc·4

May 14, 5:59 PM ET

Pagliari Aldo John 4

4 · Snap-on Inc · Filed May 14, 2026

Research Summary

AI-generated summary of this filing

Updated

Snap-on (SNA) CFO Aldo Pagliari Exercises Options, Sells Shares

What Happened
Aldo John Pagliari, Senior Vice President – Finance and Chief Financial Officer of Snap-on Inc. (SNA), exercised stock options on May 14, 2026 to acquire 8,000 shares at an exercise price of $168.70 (total cost ~$1,349,600). On the same day he sold three blocks of shares in open-market trades: 1,010 shares at a weighted-average $366.20 ($369,858), 3,029 shares at $367.09 ($1,111,927), and 1,674 shares at $367.96 ($615,957) — total open-market proceeds roughly $2.10 million. The filing also shows an 8,000-share derivative disposition tied to the option exercise (reported N/A for price), consistent with share withholding to cover the exercise/taxes.

Key Details

  • Transaction date: May 14, 2026. Exercise (code M) and multiple sales (code S) all reported same day.
  • Exercise: 8,000 shares @ $168.70 = $1,349,600 (cash paid to exercise).
  • Sales: 1,010 @ $366.20; 3,029 @ $367.09; 1,674 @ $367.96. Total sale proceeds ≈ $2,097,742. Some sales executed in multiple trades (weighted-average prices; see footnotes).
  • Notable footnotes: transaction executed under a Rule 10b5-1 plan adopted Nov 3, 2025; portion of shares were sold to cover exercise price and estimated tax liability (cashless/net share settlement) (F1, F7). Price ranges for the multiple trades are provided in the filing (F3–F5). Option was fully vested (F6).
  • Shares owned after transaction: not specified in the provided excerpt of the filing.
  • Filing timeliness: Reported and filed with period date 2026-05-14 (no late filing indicated).

Context
This is primarily an option exercise paired with immediate share sales to cover the exercise cost and tax withholding (a common “cashless” or net-share settlement pattern). Sales executed under a pre-established 10b5-1 plan generally indicate pre-planned disposition rather than ad hoc market timing. These transactions are routine for executives exercising vested options and do not, by themselves, indicate a change in company outlook.

Insider Transaction Report

Form 4
Period: 2026-05-14
Pagliari Aldo John
Sr VP - Finance & CFO
Transactions
  • Exercise/Conversion

    Common Stock

    [F1][F2]
    2026-05-14$168.70/sh+8,000$1,349,600125,200.686 total
  • Sale

    Common Stock

    [F1][F3]
    2026-05-14$366.20/sh1,010$369,858124,190.686 total
  • Sale

    Common Stock

    [F1][F4]
    2026-05-14$367.09/sh3,029$1,111,927121,161.686 total
  • Sale

    Common Stock

    [F1][F5]
    2026-05-14$367.96/sh1,674$615,957119,487.686 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F7][F6]
    2026-05-148,00018,000 total
    Exercise: $168.70Exp: 2027-02-09Common Stock (8,000 underlying)
Holdings
  • Stock Option (Right to Buy)

    [F6]
    Exercise: $161.18Exp: 2028-02-15Common Stock (26,052 underlying)
    26,052
  • Stock Option (Right to Buy)

    [F6]
    Exercise: $155.92Exp: 2029-02-14Common Stock (23,500 underlying)
    23,500
  • Stock Option (Right to Buy)

    [F6]
    Exercise: $155.34Exp: 2030-02-13Common Stock (23,500 underlying)
    23,500
  • Stock Option (Right to Buy)

    [F6]
    Exercise: $189.89Exp: 2031-02-11Common Stock (14,986 underlying)
    14,986
  • Stock Option (Right to Buy)

    [F6]
    Exercise: $211.67Exp: 2032-02-10Common Stock (11,252 underlying)
    11,252
  • Stock Option (Right to Buy)

    [F6]
    Exercise: $249.26Exp: 2033-02-09Common Stock (7,850 underlying)
    7,850
  • Stock Option (Right to Buy)

    [F8]
    Exercise: $269.00From: 2025-02-15Exp: 2034-02-15Common Stock (7,106 underlying)
    7,106
  • Stock Option (Right to Buy)

    [F8]
    Exercise: $339.73From: 2026-02-13Exp: 2035-02-13Common Stock (5,342 underlying)
    5,342
  • Stock Option (Right to Buy)

    [F8]
    Exercise: $378.55From: 2027-02-12Exp: 2036-02-12Common Stock (5,187 underlying)
    5,187
  • Restricted Stock Units

    [F9][F10]
    From: 2027-02-15Exp: 2027-02-15Common Stock (1,533 underlying)
    1,533
  • Restricted Stock Units

    [F9][F10]
    From: 2028-02-13Exp: 2028-02-13Common Stock (1,249 underlying)
    1,249
  • Restricted Stock Units

    [F9][F10]
    From: 2029-02-12Exp: 2029-02-12Common Stock (1,249 underlying)
    1,249
  • Performance Units

    [F9][F11]
    Common Stock (3,065 underlying)
    3,065
  • Performance Units

    [F9][F12]
    Common Stock (2,498 underlying)
    2,498
  • Performance Units

    [F9][F13]
    Common Stock (2,497 underlying)
    2,497
Footnotes (13)
  • [F1]The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025.
  • [F10]The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.
  • [F11]If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
  • [F12]If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
  • [F13]If the Company achieves certain goals over the 2026-2028 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
  • [F2]Includes 17.6301 shares acquired under a dividend reinvestment plan.
  • [F3]This transaction was executed in multiple trades at prices ranging from $365.56 to $366.54. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F4]This transaction was executed in multiple trades at prices ranging from $366.57 to $367.55. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F5]This transaction was executed in multiple trades at prices ranging from $367.57 to $368.51. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F6]Option fully vested.
  • [F7]Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025.
  • [F8]Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.
  • [F9]1 for 1.
Signature
/s/ Ryan S. Lovitz under Power of Attorney for Aldo J. Pagliari|2026-05-14

Documents

2 files
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POWER OF ATTORNEY (PUBLIC): 2019 POWER OF ATTORNEY